Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

Has Temu-Owner PDD's Story Changed After Double Miss?

Temu owner PDD keeps sinking. The company is prioritizing long-term competitiveness over short-term results, creating potential for an extended recovery.

MarketBeat

Tanker Dividends Are Surging, But Income Investors Need to Watch the Cycle

Frontline, Euroseas, and Nordic American Tankers raised dividends in 2026, with Frontline boosting its payout 50% after reporting its highest quarterly profit since 2004.

MarketBeat

These 3 Stocks Lowered Their Share Counts Drastically in Q1

Pinterest, Southwest Airlines, and United Therapeutics each executed significant share repurchases in Q1 2026, reducing their outstanding share counts by 16%, 5%, and 3.2%, respectively.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Annexon Eyes ‘Win Season’ With Q4 Vision Trial Data, GBS Filings Ahead

Annexon (NASDAQ:ANNX) executives used a Goldman Sachs Healthcare Conference session to outline the company’s upcoming clinical and regulatory catalysts, led by pivotal Phase III data expected in the fourth quarter for vonaprument in geographic atrophy, a form of advanced dry age-related macular dege

MarketBeat

J. M. Smucker Q4 Earnings Call Highlights

J. M. Smucker (NYSE:SJM) executives said the company is entering fiscal 2027 with momentum across key brands, while cautioning that commodity costs, tariffs and consumer behavior remain important variables in its outlook. During the company’s fiscal fourth-quarter earnings question-and-answer sessi

MarketBeat

TH International Q1 Earnings Call Highlights

TH International (NASDAQ:THCH), the operator of Tims China, reported weaker first-quarter 2026 sales as management continued to close underperforming stores, reduce discount-driven promotions and shift resources toward franchising and profitability. On the company’s earnings call, CEO Director Yong

MarketBeat

Cybersecurity Earnings: 1 AI Standout and 2 Stocks Under Pressure

Volatility was the operative word to describe the latest round of cybersecurity earnings. See who skyrocketed, and who got markets knocked down a peg.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

AirJoule Technologies: A Cool Shot at a Multibagger

AirJoule Technology is on track to comercialize its technology and unleadh a torrent of demand, hyper revenue growth, and a quick path to profits.

MarketBeat

Walmart's No. 2 Ranking Hides a Digital Transformation Story

Walmart is evolving beyond retail through advertising, e-commerce, and Sam's Club digital innovation. Learn why WMT may deserve a higher valuation

MarketBeat

Campbell's Soup Stock: Deep Value and a 7% Dividend Yield

Campbell's Soup Company is at rock bottom and too cheap to ignore, yielding more than 7% with a business recovery taking hold.

MarketBeat

Caribou Biosciences Says CRISPR CAR-T Is Pivotal-Ready, CB-011 Data Nears

Caribou Biosciences (NASDAQ:CRBU) Chief Executive Officer Rachel Haurwitz said the company is advancing two CRISPR-enabled, off-the-shelf CAR T cell therapy programs, with its lymphoma candidate vispa-cel now “pivotal-ready” and its multiple myeloma program CB-011 continuing in Phase 1 development.

MarketBeat

Oxford Instruments H2 Earnings Call Highlights

Oxford Instruments (LON:OXIG) said it delivered a stronger second half after a difficult start to the year, as improving demand from commercial semiconductor customers helped offset weaker academic markets and geopolitical uncertainty. Chief Executive Richard Tyson told investors the company was “r

MarketBeat

Corbus Pharmaceuticals Teases Cancer, Obesity Data as Key Clinical Readouts Near

Corbus Pharmaceuticals (NASDAQ:CRBP) Chief Executive Yuval Cohen outlined the company’s near-term clinical readout schedule and development plans for its two lead drug candidates during a Jefferies fireside chat hosted by biotech analyst Amin Makarem. Cohen said the Norwood, Massachusetts-based dru

MarketBeat

Hemab Therapeutics Details Post-IPO Pipeline Push, Sutacimig Phase III Plans

Hemab Therapeutics (NASDAQ:COAG) Chief Executive Officer Benny Sorensen outlined the company’s development plans following its recent initial public offering during a fireside chat with Jefferies biotech analyst Maury Raycroft. Sorensen said Hemab is pursuing a strategy to build “a multiple product

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Zepp Health Q1 Earnings Call Highlights

Zepp Health (NYSE:ZEPP) reported a stronger start to 2026, with management pointing to new Amazfit product launches, a higher-end product mix and expanding positioning in hybrid training as the main drivers of first-quarter growth. On the company’s earnings call, Founder and Chief Executive Officer

MarketBeat

CareDx Sharpens Precision Diagnostics Push With Naveris Deal, AlloHeme Plans

CareDx (NASDAQ:CDNA) executives outlined the company’s strategy to focus on precision diagnostics, expand into minimal residual disease testing and improve profitability during a Goldman Sachs-hosted discussion. Chief Executive Officer John Hanna said CareDx has reshaped its portfolio around areas

MarketBeat

Bioventus Highlights PNS, PRP Growth as Cash Flow Improves and Debt Falls

Bioventus (NASDAQ:BVS) executives outlined the company’s portfolio strategy, growth priorities and capital allocation plans during a Goldman Sachs event hosted by Jenny Rabinowitz, an analyst covering U.S. medtech and healthcare IT. Mark Singleton, Bioventus’ senior vice president and chief financi

MarketBeat

Vail Resorts Q3 Earnings Call Highlights

Vail Resorts (NYSE:MTN) said historically poor weather across the Western United States continued to weigh on fiscal third-quarter results, pressuring visitation and revenue at its mountain resorts while management emphasized that its advance commitment pass model and cost controls helped cushion th

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Gloo Q1 Earnings Call Highlights

Gloo (NASDAQ:GLOO) reported fiscal first-quarter revenue and adjusted EBITDA ahead of its own guidance and Wall Street consensus, as executives pointed to momentum from large strategic customers, recent acquisitions and growing demand for AI-enabled technology and marketing tools across faith-based

MarketBeat

Mama's Creations Q1 Earnings Call Highlights

Mama's Creations (NASDAQ:MAMA) reported sharply higher first-quarter fiscal 2027 results, with management pointing to new retail placements, the Crown I acquisition and broader customer growth as the main drivers, even as gross margins were pressured by launch-related costs. Chairman and CEO Adam L

MarketBeat

Mission Produce Q2 Earnings Call Highlights

Mission Produce (NASDAQ:AVO) said its fiscal second quarter was pressured by an unusually high-supply avocado market, particularly from Mexico, which drove prices to multi-year lows and compressed margins despite higher avocado volumes. President and Chief Executive Officer John Pawlowski, who form

MarketBeat

Motorcar Parts of America Q4 Earnings Call Highlights

Motorcar Parts of America (NASDAQ:MPAA) reported stronger fiscal fourth-quarter and full-year results, with management pointing to sales momentum, new business commitments and improving profitability as key drivers heading into fiscal 2027. Chairman, President and Chief Executive Officer Selwyn Jof

MarketBeat

Amprius Insiders Are Selling: Should Investors Be Worried?

Amprius Technology is on track to set a new all-time high later this year after it reports Q2 results and guidance. Short interest suggests a squeeze is possible.

MarketBeat

3 Stocks With Fresh Catalysts to Watch Before the July 4

Broadcom, Palo Alto Networks, and Planet Labs each reported strong results and offer potential upside as investors position for the second half of 2025.

MarketBeat

A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus

A weaker dollar means international revenue can have a bigger impact, and these companies might be positioned to take advantage of an otherwise tough situation.

1 … 8 9 10 11

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.